The company's financial position has deteriorated significantly, evidenced by a negative equity base of $67 million and a debt-to-equity ratio that spiked to 48.76 in 2026Q3.
| Metric | TTM | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 | Jun'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 |
|---|
| Total Current Assets | 2.65B | 1.61B | 1.62B | 1.83B | 1.73B | 1.83B | 2.02B | 1.3B | 1.31B | 1.51B | 1.49B | 1.43B | 1.4B | 1.42B | 1.38B | 1.28B | 1.12B | 1.18B | 1.25B | 1.03B | 1.01B | 1.09B | 1.04B | 951M | 1B | 1.1B | 1.45B | 1.12B | 798.7M | 673.5M | 573.8M |
| Cash & Short-Term Investments | 1.19B | 167M | 202M | 367M | 183M | 319M | 871M | 111M | 131M | 418M | 401M | 382M | 329M | 299M | 267M | 259M | 87M | 206M | 214M | 182M | 192M | 293M | 232M | 172M | 177M | 251M | 245M | 132M | 89.7M | 101M | 90.8M |
| Cash Only | 1.19B | 167M | 202M | 367M | 183M | 319M | 871M | 111M | 131M | 418M | 401M | 382M | 329M | 299M | 267M | 259M | 87M | 206M | 214M | 182M | 192M | 293M | 232M | 172M | 177M | 251M | 245M | 132M | 89.7M | 101M | 90.8M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 671M | 821M | 695M | 688M | 681M | 604M | 648M | 631M | 600M | 565M | 569M | 519M | 546M | 580M | 576M | 525M | 540M | 486M | 505M | 460M | 435M | 411M | 460M | 463M | 483M | 514M | 633M | 610M | 428.5M | 357M | 315.1M |
| Days Sales Outstanding | 38.69 | 42.18 | 35.76 | 33.99 | 34.97 | 30.03 | 35.19 | 37.06 | 35.76 | 34.53 | 36.05 | 33.5 | 36.14 | 37.65 | 38.45 | 36.63 | 37.66 | 32.55 | 34.96 | 34.64 | 34.19 | 34.19 | 38.83 | 40.78 | 43.41 | 48.07 | 56.59 | 55.62 | 57.05 | 51.45 | 51.86 |
| Inventory | 588M | 523M | 637M | 696M | 755M | 752M | 454M | 512M | 506M | 459M | 443M | 385M | 386M | 394M | 384M | 382M | 367M | 366M | 384M | 309M | 292M | 323M | 301M | 264M | 258M | 281M | 376M | 319M | 211.9M | 170.3M | 138.8M |
| Days Inventory Outstanding | 55.12 | 48.82 | 57.15 | 56.23 | 59.7 | 65.98 | 45.19 | 53.35 | 53.38 | 50.66 | 51.19 | 43.97 | 44.44 | 44.66 | 44.09 | 46.99 | 46.1 | 43.46 | 45.48 | 40.85 | 39.62 | 47.21 | 46.03 | 43.31 | 40.8 | 44.23 | 66.98 | 65.3 | 73.32 | 62.34 | 56.88 |
| Other Current Assets | 205M | 97M | 88M | 77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104M | 92M | 106M | 106M | 113M | 530M | 122M | 150M | 81M | 88M | 63M | 50M | 52M | 134M | 57M | 200M | 55M | 91M | 45.2M | 29.1M |
| Total Non-Current Assets | 3.79B | 3.95B | 4.13B | 4.12B | 4.43B | 4.5B | 4.19B | 3.81B | 3.75B | 3.06B | 3.03B | 2.73B | 2.86B | 2.89B | 2.98B | 2.88B | 3.43B | 3.4B | 3.46B | 2.63B | 2.61B | 2.53B | 2.79B | 2.7B | 2.63B | 2.89B | 2.9B | 3.02B | 2.23B | 2.1B | 1.61B |
| Property, Plant & Equipment | 1.59B | 1.6B | 1.68B | 1.69B | 1.68B | 1.63B | 1.39B | 1.03B | 996M | 931M | 906M | 918M | 977M | 1.02B | 1.08B | 1.04B | 979M | 955M | 960M | 976M | 1B | 999M | 1.05B | 1.07B | 922M | 1.05B | 1.08B | 1.05B | 596.3M | 570.6M | 551.4M |
| Fixed Asset Turnover | 4.24x | 4.44x | 4.23x | 4.37x | 4.24x | 4.49x | 4.82x | 6.01x | 6.15x | 6.42x | 6.36x | 6.16x | 5.64x | 5.51x | 5.06x | 5.03x | 5.35x | 5.71x | 5.49x | 4.97x | 4.63x | 4.39x | 4.11x | 3.87x | 4.40x | 3.73x | 3.78x | 3.80x | 4.60x | 4.44x | 4.02x |
| Goodwill | 1.23B | 1.23B | 1.23B | 1.25B | 1.56B | 1.57B | 1.58B | 1.59B | 1.6B | 1.2B | 1.2B | 1.07B | 1.1B | 1.1B | 1.11B | 1.07B | 1.65B | 1.63B | 1.66B | 855M | 744M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 49M | 566M | 681M | 712M | 884M | 918M | 894M | 912M | 929M | 722M | 735M | 585M | 611M | 627M | 642M | 633M | 646M | 662M | 683M | 348M | 604M | 599M | 1.38B | 1.38B | 1.3B | 1.57B | 1.54B | 1.5B | 1.52B | 1.19B | 704.7M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 917M | 558M | 545M | 462M | 315M | 378M | 328M | 274M | 222M | 210M | 187M | 165M | 174M | 138M | 144M | 142M | 144M | 149M | 158M | 186M | 257M | 186M | 364M | 248M | 306M | 272M | 284M | 465M | 442M | 346.9M | 349M |
| Total Assets | 6.44B | 5.56B | 5.75B | 5.95B | 6.16B | 6.33B | 6.21B | 5.12B | 5.06B | 4.57B | 4.52B | 4.16B | 4.26B | 4.31B | 4.36B | 4.16B | 4.55B | 4.58B | 4.71B | 3.67B | 3.62B | 3.62B | 3.83B | 3.65B | 3.63B | 4B | 4.35B | 4.13B | 3.03B | 2.78B | 2.18B |
| Asset Turnover | 1.17x | 1.28x | 1.23x | 1.24x | 1.15x | 1.16x | 1.08x | 1.21x | 1.21x | 1.31x | 1.28x | 1.36x | 1.29x | 1.30x | 1.26x | 1.26x | 1.15x | 1.19x | 1.12x | 1.32x | 1.28x | 1.21x | 1.13x | 1.13x | 1.12x | 0.98x | 0.94x | 0.97x | 0.90x | 0.91x | 1.02x |
| Asset Growth % | 14.67% | -3.3% | -3.26% | -3.46% | -2.78% | 1.95% | 21.44% | 1.11% | 10.65% | 1.22% | 8.5% | -2.21% | -1.23% | -1.01% | 4.61% | -8.61% | -0.46% | -2.8% | 28.42% | 1.38% | -0.03% | -5.66% | 4.98% | 0.61% | -9.14% | -8.22% | 5.35% | 36.37% | 9.07% | 27.5% | 14.28% |
| Total Current Liabilities | 3.15B | 1.92B | 1.57B | 1.92B | 1.78B | 2.06B | 1.42B | 1.44B | 1.2B | 1.81B | 1.56B | 1.41B | 1.64B | 1.13B | 2.06B | 1.36B | 1.65B | 1.94B | 1.66B | 1.43B | 1.13B | 1.35B | 1.27B | 1.45B | 1.23B | 1.07B | 1.54B | 1.37B | 1.23B | 892.7M | 623.9M |
| Accounts Payable | 0 | 838M | 950M | 1.02B | 960M | 930M | 575M | 507M | 507M | 501M | 490M | 431M | 440M | 413M | 412M | 423M | 409M | 381M | 418M | 329M | 329M | 347M | 310M | 312M | 330M | 314M | 378M | 206M | 226M | 143.4M | 155.4M |
| Days Payables Outstanding | 66.38 | 78.23 | 85.24 | 82.48 | 75.91 | 81.6 | 57.23 | 52.83 | 53.48 | 55.3 | 56.62 | 49.22 | 50.66 | 46.82 | 47.3 | 52.04 | 51.37 | 45.24 | 49.5 | 43.49 | 44.64 | 50.72 | 47.4 | 51.18 | 52.19 | 49.42 | 67.34 | 42.17 | 78.2 | 52.49 | 63.68 |
| Short-Term Debt | 1.68B | 4M | 4M | 50M | 237M | 300M | 0 | 396M | 199M | 804M | 523M | 395M | 718M | 202M | 1.15B | 459M | 671M | 998M | 755M | 574M | 308M | 361M | 291M | 574M | 332M | 319M | 773M | 741M | 778M | 373.5M | 193M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.48B | 179M | 190M | 262M | 176M | 219M | 288M | 158M | 154M | 162M | 192M | 189M | 119M | 155M | 165M | 0 | 0 | 0 | 0 | 17M | 19M | 26M | 24M | 28M | 54M | 0 | 36M | 421M | 377M | 375.8M | 275.5M |
| Current Ratio | 0.84x | 0.84x | 1.03x | 0.95x | 0.97x | 0.89x | 1.42x | 0.91x | 1.09x | 0.84x | 0.95x | 1.02x | 0.85x | 1.25x | 0.67x | 0.94x | 0.68x | 0.61x | 0.75x | 0.72x | 0.89x | 0.81x | 0.82x | 0.66x | 0.82x | 1.03x | 0.94x | 0.82x | 0.65x | 0.75x | 0.92x |
| Quick Ratio | 0.65x | 0.57x | 0.63x | 0.59x | 0.54x | 0.52x | 1.10x | 0.55x | 0.67x | 0.58x | 0.67x | 0.74x | 0.62x | 0.90x | 0.48x | 0.66x | 0.46x | 0.42x | 0.52x | 0.51x | 0.63x | 0.57x | 0.59x | 0.47x | 0.61x | 0.77x | 0.70x | 0.58x | 0.48x | 0.56x | 0.70x |
| Cash Conversion Cycle | 27.43 | 12.78 | 7.68 | 7.73 | 18.76 | 14.41 | 23.15 | 37.58 | 35.66 | 29.89 | 30.62 | 28.25 | 29.92 | 35.5 | 35.23 | 31.59 | 32.38 | 30.77 | 30.93 | 32 | 29.17 | 30.68 | 37.45 | 32.91 | 32.03 | 42.87 | 56.23 | 78.75 | 52.18 | 61.3 | 45.06 |
| Total Non-Current Liabilities | 3.19B | 3.16B | 3.69B | 3.64B | 3.65B | 3.69B | 3.89B | 3.12B | 3.13B | 2.22B | 2.66B | 2.64B | 2.47B | 3.03B | 2.43B | 2.88B | 2.83B | 2.81B | 3.42B | 2.07B | 2.64B | 2.82B | 1.03B | 986M | 1.05B | 1.03B | 1.02B | 1.19B | 719.8M | 849.3M | 622.2M |
| Long-Term Debt | 2.81B | 2.48B | 2.48B | 2.48B | 2.47B | 2.48B | 2.78B | 2.29B | 2.28B | 1.39B | 1.79B | 1.8B | 1.59B | 2.17B | 1.57B | 2.13B | 2.12B | 2.15B | 2.72B | 1.46B | 1.97B | 2.12B | 475M | 495M | 678M | 685M | 590M | 702M | 704M | 565.9M | 356.3M |
| Capital Lease Obligations | 591M | 305M | 334M | 310M | 314M | 301M | 278M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 82M | 20M | 22M | 28M | 66M | 67M | 62M | 50M | 72M | 61M | 82M | 95M | 103M | 119M | 119M | 140M | 24M | 23M | 97M | 90M | 129M | 82M | 174M | 115M | 142M | 147M | 224M | 237M | 200.4M | 170.7M | 148.4M |
| Other Non-Current Liabilities | 356M | 351M | 848M | 825M | 791M | 834M | 767M | 780M | 778M | 770M | 784M | 750M | 768M | 742M | 739M | 619M | 677M | 640M | 632M | 516M | 547M | 618M | 377M | 376M | 231M | 194M | 204M | 255M | 228M | 112.7M | 117.5M |
| Total Liabilities | 6.34B | 5.08B | 5.26B | 5.56B | 5.43B | 5.74B | 5.3B | 4.56B | 4.33B | 4.03B | 4.22B | 4.05B | 4.1B | 4.17B | 4.49B | 4.25B | 4.47B | 4.75B | 5.08B | 3.5B | 3.77B | 4.17B | 2.29B | 2.44B | 2.28B | 2.1B | 2.56B | 2.56B | 1.94B | 1.74B | 1.25B |
| Total Debt | 4.49B | 2.88B | 2.9B | 2.92B | 3.1B | 3.17B | 3.12B | 2.68B | 2.48B | 2.19B | 2.31B | 2.19B | 2.31B | 2.37B | 2.72B | 2.58B | 2.79B | 3.15B | 3.48B | 2.04B | 2.27B | 2.48B | 766M | 1.07B | 1.01B | 1B | 1.36B | 1.44B | 1.48B | 939.4M | 549.3M |
| Net Debt | 3.3B | 2.71B | 2.7B | 2.56B | 2.92B | 2.85B | 2.25B | 2.57B | 2.35B | 1.78B | 1.91B | 1.81B | 1.98B | 2.07B | 2.45B | 2.33B | 2.71B | 2.94B | 3.26B | 1.85B | 2.08B | 2.19B | 534M | 897M | 833M | 753M | 1.11B | 1.31B | 1.38B | 838.4M | 458.5M |
| Debt / Equity | 48.76x | 5.98x | 5.90x | 7.54x | 4.26x | 5.35x | 3.44x | 4.80x | 3.42x | 4.05x | 7.78x | 18.57x | 15.02x | 16.25x | - | - | 33.67x | - | - | 11.91x | - | - | 0.50x | 0.88x | 0.75x | 0.53x | 0.76x | 0.92x | 1.37x | 0.91x | 0.59x |
| Debt / EBITDA | 3.45x | 2.06x | 2.52x | 2.75x | 3.37x | 2.19x | 2.16x | 2.08x | 1.92x | 1.71x | 1.88x | 1.87x | 2.03x | 2.09x | 2.58x | 2.41x | 2.40x | 2.56x | 3.17x | 1.93x | 2.28x | 2.51x | 0.72x | 1.02x | 1.07x | 1.20x | 1.39x | 1.64x | 2.19x | 1.58x | 1.03x |
| Net Debt / EBITDA | 2.54x | 1.94x | 2.35x | 2.41x | 3.17x | 1.97x | 1.56x | 2.00x | 1.82x | 1.38x | 1.55x | 1.54x | 1.74x | 1.82x | 2.33x | 2.16x | 2.32x | 2.39x | 2.97x | 1.76x | 2.09x | 2.21x | 0.50x | 0.86x | 0.88x | 0.90x | 1.13x | 1.49x | 2.04x | 1.41x | 0.86x |
| Interest Coverage | 10.38x | 11.67x | 4.86x | 3.31x | 7.26x | 10.68x | 13.74x | 12.25x | 14.24x | 13.60x | 12.99x | 10.69x | 9.93x | 8.17x | 7.43x | 5.58x | 6.79x | 6.04x | 5.13x | 7.58x | 6.14x | 10.23x | - | - | - | - | - | - | - | - | - |
| Total Equity | 92M | 482M | 492M | 388M | 729M | 592M | 908M | 559M | 726M | 542M | 297M | 118M | 154M | 146M | -135M | -86M | 83M | -175M | -370M | 171M | -156M | -553M | 1.54B | 1.22B | 1.35B | 1.9B | 1.79B | 1.57B | 1.09B | 1.04B | 932.8M |
| Equity Growth % | -163.08% | -2.03% | 26.8% | -46.78% | 23.14% | -34.8% | 62.43% | -23% | 33.95% | 82.49% | 151.69% | -23.38% | 5.48% | 208.15% | -56.98% | -203.61% | 147.43% | 52.7% | -316.37% | 209.62% | 71.79% | -135.91% | 26.75% | -10.27% | -28.74% | 5.91% | 14.27% | 44.67% | 4.75% | 11.06% | -1.18% |
| Book Value per Share | 0.76 | 3.88 | 3.94 | 3.12 | 5.88 | 4.65 | 7.11 | 4.31 | 5.52 | 4.12 | 2.25 | 0.89 | 1.17 | 1.10 | -1.02 | -0.62 | 0.59 | -1.24 | -2.61 | 1.11 | -1.02 | -3.09 | 7.18 | 5.51 | 5.77 | 7.93 | 7.49 | 6.54 | 5.23 | 4.92 | 4.51 |
| Total Shareholders' Equity | -67M | 321M | 328M | 220M | 556M | 411M | 908M | 559M | 726M | 542M | 297M | 118M | 154M | 146M | -135M | -86M | 83M | -175M | -370M | 171M | -156M | -553M | 1.54B | 1.22B | 1.35B | 1.9B | 1.79B | 1.57B | 1.09B | 1.04B | 932.8M |
| Common Stock | 131M | 131M | 131M | 131M | 131M | 131M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 159M | 250M | 250M | 250M | 250M | 250M | 250M | 250M | 250M | 0 | 0 | 0 |
| Retained Earnings | 223M | 432M | 250M | 583M | 1.05B | 1.04B | 3.57B | 3.15B | 2.8B | 2.44B | 2.16B | 1.92B | 1.74B | 1.56B | 1.35B | 1.14B | 920M | 640M | 386M | 185M | 3.94B | 3.68B | 2.85B | 2.56B | 2.27B | 2.14B | 2.07B | 1.84B | 1.38B | 1.21B | 1.08B |
| Treasury Stock | 0 | -1.4B | -1.19B | -1.25B | -1.35B | -1.4B | -3.31B | -3.19B | -2.66B | -2.44B | -2.32B | -2.24B | -2.04B | -1.87B | -1.88B | -1.77B | -1.24B | -1.21B | -1.27B | -445M | -4.53B | -4.46B | -1.57B | -1.51B | -1.07B | -441M | -451M | -392M | -392M | 0 | 0 |
| Accumulated OCI | -152M | -157M | -155M | -493M | -479M | -546M | -640M | -602M | -547M | -543M | -570M | -502M | -417M | -367M | -396M | -250M | -371M | -347M | -179M | -209M | -215M | -352M | -287M | -348M | -318M | -246M | -200M | -180M | -612.4M | -474.8M | -409.8M |
| Minority Interest | 159M | 161M | 164M | 168M | 173M | 181M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Excessive leverage and thin equity
As reported in recent financial statements, Clorox's equity position has deteriorated significantly, shifting from a positive $321 million in 2025Q4 to a negative $67 million by 2026Q3, which highlights a concerning trend of capital erosion that warrants close monitoring by long-term institutional investors.
The rapid depletion of equity suggests that the company's recent earnings performance and capital allocation decisions have failed to preserve shareholder value. This trajectory indicates that the balance sheet is becoming increasingly reliant on debt to sustain operations, which may limit future financial flexibility.
Based on the latest quarterly data, the company's debt-to-equity ratio has surged to an alarming 48.76 in 2026Q3, a stark contrast to the 5.98 reported in 2025Q4, suggesting that the firm's reliance on external financing has reached a level that may constrain future strategic initiatives.
The dramatic spike in leverage appears to be driven by both rising debt levels and a shrinking equity base, creating a precarious financial structure. Investors should consider whether this level of indebtedness is sustainable given the current volatility in operating cash flows and the potential for higher interest expenses.
According to recent SEC filings, the current ratio has consistently remained below 1.0, reaching 0.84 in 2026Q3, which indicates that the company may face challenges in meeting its short-term obligations without relying on external credit facilities or further debt issuance to bridge the gap.
A current ratio consistently below unity suggests that current assets are insufficient to cover current liabilities, pointing to a structural liquidity constraint. This lack of a safety buffer may leave the company vulnerable to unexpected operational disruptions or sudden shifts in the credit environment.
As indicated by the provided balance sheet data, net property, plant, and equipment have remained stagnant at approximately $1.6 billion over the last ten quarters, while goodwill remains fixed at $1.2 billion, reflecting a business model that requires significant ongoing capital investment to maintain its market position.
The high concentration of goodwill relative to total assets suggests that the company's valuation is heavily dependent on past acquisitions, which may be subject to impairment risk if the underlying business units underperform. The lack of growth in net PPE further implies that capital expenditures are primarily focused on maintenance rather than expansion.
Quick answers to the most common questions about buying CLX stock.
As of 2025, The Clorox Company (CLX) had total assets of $5.56B including $1.61B in current assets.
The Clorox Company (CLX) carries total debt of $2.88B, offset by $167.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
The Clorox Company (CLX) has total shareholders' equity (book value) of $321.0M ($3.88 book value per share). Book value represents the net worth of the company belonging to common stock holders.
The Clorox Company (CLX) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.